NERVGEN PHARMA CORP. (NGEN) Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised

NERVGEN PHARMA CORP. Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised

NERVGEN PHARMA CORP. (NGEN) had Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised of CAD 27.37 million as of 2025-12-31, per its 40-F filed 2026-03-31.

Financial Statements › Notes › Income Taxes

ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised · last filed 2026-03-31

• 2025-12-31: Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised 27.37M CAD.
• 2024-12-31: Deductible Temporary Differences For Which No Deferred Tax Asset Is Recognised 21.63M CAD.